Compare BTAI & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTAI | ABLV |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 39.5M |
| IPO Year | 2018 | N/A |
| Metric | BTAI | ABLV |
|---|---|---|
| Price | $1.60 | $0.68 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | 463.9K | ★ 1.1M |
| Earning Date | 11-12-2025 | 01-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $752,000.00 | ★ $114,319,869.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $441.98 | N/A |
| P/E Ratio | ★ N/A | $14.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.17 | $0.59 |
| 52 Week High | $9.26 | $1.77 |
| Indicator | BTAI | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 36.65 | 39.81 |
| Support Level | $1.50 | $0.74 |
| Resistance Level | $1.89 | $0.75 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 13.77 | 12.75 |
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.